Literature DB >> 9535895

Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries.

R S Walikonis1, J F Poduslo.   

Abstract

Recent studies demonstrate that cAMP levels are tightly controlled during demyelination and remyelination in Schwann cells as cAMP decreases to 8-10% of normal following both sciatic nerve crush or permanent transection injury and only begins to increase in the crushed nerve after remyelination (Poduslo, J. F., Walikonis, R. S., Domec, M., Berg, C. T., and Holtz-Heppelmann, C. J. (1995) J. Neurochem. 65, 149-159). To investigate the mechanisms responsible for this change in cAMP levels, cAMP phosphodiesterase (PDE) and adenylyl cyclase activities were determined before and after sciatic nerve injury. Basal cAMP PDE activity in soluble endoneurial homogenates of normal nerve was 34.9 +/- 1.9 pmol/mg of protein/min (chi +/- S.E.; n = 10). This activity increased about 3-fold within 6 days following both injuries. Basal PDE activity remained elevated in the transected nerve, but declined to 70 pmol/mg of protein/min in the crushed nerve at 21 and 35 days following injury. Isozyme-specific inhibitors and stimulators were used to identify the PDE families in the sciatic nerve. The low Km cAMP-specific (PDE4) and the Ca2+/calmodulin-stimulated (PDE1) families were found to predominate in assays using endoneurial homogenates. The PDE4 inhibitor rolipram also increased cAMP levels significantly after incubation of endoneurial tissue with various isozyme-specific inhibitors, indicating that PDE4 plays a major role in determining cAMP levels. PDE4 mRNA was localized by in situ hybridization to cells identified as Schwann cells by colabeling of S100, a Schwann cell specific protein. Adenylyl cyclase activity declined following injury, from 3.7 pmol/mg of protein/min in normal nerve to 0.70 pmol/mg/min by 7 days following injury. Both decreased synthesis and increased degradation contribute, therefore, to the reduced levels of cAMP following peripheral nerve injury and are likely critical to the process of Wallerian degeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535895     DOI: 10.1074/jbc.273.15.9070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 2.  Signaling axis in schwann cell proliferation and differentiation.

Authors:  Toru Ogata; Shin-ichi Yamamoto; Kozo Nakamura; Sakae Tanaka
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

3.  Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation.

Authors:  Allison S Limpert; Bruce D Carter
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

4.  Influence of hypothalamic proline-rich peptide on the level of [14C]glucose utilization during crush syndrome.

Authors:  G A Kevorkian; G L Marukhyan; L N Arakelyan; A G Guevorkian; A A Galoyan
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

5.  Aberrant cAMP metabolism in NF1 malignant peripheral nerve sheath tumor cells.

Authors:  Ian Dang; George H De Vries
Journal:  Neurochem Res       Date:  2011-03-05       Impact factor: 3.996

6.  Deep Sequencing Reveals the Significant Involvement of cAMP-Related Signaling Pathways Following Sciatic Nerve Crush.

Authors:  Jun Yu; Sijia Wang; Chen Wu; Sheng Yi
Journal:  Neurochem Res       Date:  2017-10-09       Impact factor: 3.996

7.  Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.

Authors:  E M Medina-Rodríguez; F J Arenzana; J Pastor; M Redondo; V Palomo; R García de Sola; C Gil; A Martínez; A Bribián; F de Castro
Journal:  Cell Mol Life Sci       Date:  2013-05-10       Impact factor: 9.261

8.  E-cadherin expression in postnatal Schwann cells is regulated by the cAMP-dependent protein kinase a pathway.

Authors:  Audrita T Crawford; Darshan Desai; Pradeepa Gokina; Sayantani Basak; Haesun A Kim
Journal:  Glia       Date:  2008-11-15       Impact factor: 7.452

9.  p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.

Authors:  Benjamin D Sachs; George S Baillie; Julianne R McCall; Melissa A Passino; Christian Schachtrup; Derek A Wallace; Allan J Dunlop; Kirsty F MacKenzie; Enno Klussmann; Martin J Lynch; Shoana L Sikorski; Tal Nuriel; Igor Tsigelny; Jin Zhang; Miles D Houslay; Moses V Chao; Katerina Akassoglou
Journal:  J Cell Biol       Date:  2007-06-18       Impact factor: 10.539

Review 10.  Cyclic AMP signaling: a molecular determinant of peripheral nerve regeneration.

Authors:  Eric P Knott; Mazen Assi; Damien D Pearse
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.